首页> 外文期刊>Journal of Intensive Care >Timing of administration of epinephrine predicts the responsiveness to epinephrine in norepinephrine-refractory septic shock: a retrospective study
【24h】

Timing of administration of epinephrine predicts the responsiveness to epinephrine in norepinephrine-refractory septic shock: a retrospective study

机译:肾上腺素的给药时间可预测去甲肾上腺素难治性感染性休克对肾上腺素的反应性:一项回顾性研究

获取原文
           

摘要

Background Currently, the appropriate method of management of patients with refractory septic shock remains unclear. This study aimed to evaluate the factors associated with response to epinephrine in norepinephrine-refractory septic shock. Methods A retrospective single-center observational study was performed using data from adult patients (≥ 18?years old) admitted to our emergency and medical intensive care unit (ICU) from January 2014 to December 2017 who had received epinephrine to treat norepinephrine-refractory septic shock. The response was considered positive if there was increase in mean arterial pressure of 10?mmHg or decrease in arterial lactate level 3?h after epinephrine administration. Results Forty-one patients were included: 24 responders (59%) and 17 non-responders (41%). Responders showed higher rate of survival from shock (92% vs. 18%; P ?0.001), and 28-day survival (83% vs. 18%; P ?0.001). In multivariable analysis, time of epinephrine administration after ICU admission (odds ratio [OR] 0.48; 95% confidence interval [CI] 0.27–0.87; P =?0.011) and SOFA score (OR 0.19; 95% CI 0.04–0.88; P =?0.034) were associated with epinephrine response. Time of epinephrine administration was also significantly associated with survival from shock (OR 0.42; P =?0.005) and 28-day survival (OR 0.14; P =?0.006), while SOFA score did not. Using inverse probability of treatment weighing (IPTW) adjustment of propensity score, epinephrine administration later than 24?h after ICU admission was associated with poor response (OR 0.07; 95% CI 0.02–0.21; P ?0.001). Conclusions Early administration of epinephrine after ICU admission (i.e., within 24?h) is associated with better hemodynamic status in patients with refractory septic shock.
机译:背景技术目前,尚不清楚治疗难治性败血性休克患者的适当方法。这项研究旨在评估与去甲肾上腺素难治性感染性休克中对肾上腺素反应相关的因素。方法采用回顾性单中心观察性研究,研究对象为2014年1月至2017年12月接受急诊和医疗重症监护病房(ICU)并接受肾上腺素治疗去甲肾上腺素难治性脓毒症的成年患者(≥18岁)的数据休克。如果肾上腺素给药后平均动脉压升高10?mmHg或动脉血乳酸水平降低3?h,则该反应被认为是阳性的。结果共纳入41例患者:24位缓解者(59%)和17位无缓解者(41%)。应答者显示出较高的休克生存率(92%比18%; P <0.001)和28天生存率(83%比18%; P <0.001)。在多变量分析中,ICU入院后肾上腺素给药时间(赔率[OR] 0.48; 95%置信区间[CI] 0.27-0.87; P =?0.011)和SOFA评分(OR 0.19; 95%CI 0.04–0.88; P =?0.034)与肾上腺素反应有关。肾上腺素的给药时间也与休克生存率(OR 0.42; P = 0.005)和28天生存率(OR 0.14; P = 0.006)显着相关,而SOFA评分则没有。使用治疗加权倾向的逆加权(IPTW)调整倾向评分,肾上腺素在ICU入院后24小时之内给药与不良反应相关(OR 0.07; 95%CI 0.02-0.21; P <0.001)。结论难治性败血性休克患者在ICU入院后即24小时之内尽早给予肾上腺素可改善血液动力学状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号